Ams Osram's Rally Builds on Multiple Fronts: Patent Claims, Record Orders, and a Refinancing Push

Ams Osram files patent suits against Refond in Germany, while shares surge 25% in a month on record design wins and upbeat Q2 results.

The Austrian chipmaker's legal team has moved against a Chinese distributor, filing two patent infringement suits in Germany over automotive LED products. The target, Refond Optoelectronics, stands accused of selling components that allegedly breach Ams Osram's intellectual property, with the company demanding injunctive relief, damages, and the recall and destruction of affected goods.

Investors took the news in stride. The shares climbed 3.9 percent to €21.10 on Monday, extending a remarkable run that has seen the stock gain 25 percent over the past month. That momentum, however, has deeper roots than the legal action alone.

A Quarter That Exceeded Expectations

The foundation for the renewed investor confidence was laid on August 4, when the company reported second-quarter 2026 results that landed at the upper end of its own guidance. Revenue reached €805 million, a 4 percent year-on-year increase driven primarily by the automotive and industrial segments.

Adjusted EBITDA came in at €136 million, though profitability showed some strain. The margin contracted 190 basis points to 16.9 percent, while free cash flow swung to minus €119 million — a sharp deterioration from the minus €14 million recorded in the prior-year quarter and a far cry from the positive €37 million posted in Q1 2026. Management attributed the pressure to restructuring costs, higher precious metal prices, and a softer US dollar, while flagging a return to positive free cash flow by 2027.

For the current quarter, the company guided to revenue between €770 million and €870 million, with an adjusted EBITDA margin of 16.0 percent, plus or minus 1.5 percentage points, assuming an exchange rate of €1.15 per dollar.

Design Wins and a Datacenter Boost

The numbers tell only part of the story. Core semiconductor activity grew 13 percent like-for-like, and the company touted design wins exceeding €1.6 billion in the second quarter alone — roughly €2.5 billion for the first half of 2026, which management called a record, underpinned by strength in industrial and automotive markets.

Reuters reported that the stock had surged as much as 41 percent at one point following the results and news of a datacenter-related contract. Progress on chips for augmented-reality smart glasses added to the optimism, with the company saying it had completed key steps toward series production of the light source — a field analysts see as a significant future growth driver.

Analyst Revisions Follow the Rally

The share price action drew a response from the sell side. Kepler Cheuvreux lifted its rating from "Reduce" to "Hold" in early August, raising its price target from CHF 10.50 to CHF 17. UBS reaffirmed its buy recommendation and bumped its target to CHF 22. Jefferies highlighted advances in digital photonics, calling Ams Osram the "cheapest stock in the global semiconductor sector" with "considerable upside potential," pointing to long-term opportunities in smart glasses and AI datacenter optics. The Zürcher Kantonalbank described the core business as "very positive" and said the company remained "on a good path."

Refinancing and Portfolio Moves

Alongside the earnings release, the company announced a pro-rata public tender offer worth €120 million to €150 million, aimed at holders of its 2027 convertible bonds and 2029 senior notes. The buyback is slated to take place within 120 days of closing the Infineon transaction.

That deal, completed on July 1, brought in €570 million in cash from the sale of the non-optical analog and mixed-signal sensor business, with around 230 employees moving to Infineon. The same day marked the establishment of a dedicated digital photonics business line, designed to accelerate the innovation pipeline in AR glasses and datacenter optics — the very areas analysts have flagged as the company's growth engine.

A Stock for the Brave

Despite the recent surge, the shares still sit roughly 24 percent below their 52-week high of €26.70 reached in May, though they remain 175 percent above December's trough. With annualized 30-day volatility of 88 percent, this remains a stock for risk-tolerant investors.

Trading about 9.2 percent above its 50-day moving average of €19.33, the technical picture supports the near-term uptrend. The stock has now gained 151 percent since the start of the year, a rally that combines legal defense of a margin-rich core business, record order momentum, and a balance sheet being reshaped for the next phase of growth.